mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.8 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |